Maintenance on the bayer medrad stellant injectors

Ended Definitive Contract Awarded Last action

Contract number
36C25518C0189
Awardee
Awarding agency
Obligated
$142,967

Award facts

Opportunity
Contract value 90% obligated
  • $142,966.85 Current, with exercised options
  • $158,696.57 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Wichita, KS 67218, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00007 · DE-obligate unused funds -$4,296
Supplemental Agreement for work within scope P00006 · OPT year 4 - medrad injector maintenance $28,404
Supplemental Agreement for work within scope P00005 · To incorporate far clause 52.223-99 and VHA supplemental contract requirements for ensuring adequate covid-19 safety protocols for federal contractors into this… $0
Exercise an Option P00004 · Exercise option year 3 - medrad injector maintenance service $28,404
Exercise an Option P00003 · Exercise option year 2 - medrad injector maintenance service $28,404
Funding Only Action P00002 · Funding reduced for equipment no longer in use. -$5,243
Exercise an Option P00001 · Maintenance on the bayer medrad stellant injectors OYI $33,647
Original award $33,647

About this award

This is a firm fixed price definitive contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Bayer Healthcare LLC, through its Bayer Radiology division, to provide maintenance on Bayer MEDRAD Stellant injectors. The $158,696.57 contract will deliver preventative maintenance, emergency repairs, software upgrades, and service plans for these specialized medical devices used in VA hospitals nationwide. Bayer is an established provider of radiology equipment and services to federal agencies, holding a General Services Administration (GSA) Schedule contract and having received over $15 million in prior prime contract awards from the VA and Defense Health Agency (DHA). This contract does not have a set-aside designation. Bayer has also supported research projects as a subrecipient, collaborating with the National Institutes of Health to develop imaging biomarkers for cancer immunotherapy.

Quick answers

Who was awarded contract 36C25518C0189?

36C25518C0189 was awarded to Bayer Healthcare LLC by Veterans Integrated Service Network 15 (Veterans Health Administration) on July 20, 2018.

How much is contract 36C25518C0189 worth?

The government has obligated $142,967 on 36C25518C0189. Its potential value, with all options, is $158,697.

Was contract 36C25518C0189 competed?

The extent of competition for 36C25518C0189 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award